Literature DB >> 10585317

Can dialysis therapy be improved? A report from the ESRD Core Indicators Project.

W M McClellan1, D L Frankenfield, P R Frederick, W D Flanders, A Alfaro-Correa, M Rocco, S D Helgerson.   

Abstract

We assessed the association between quality improvement interventions conducted during the End-Stage Renal Disease (ESRD) Core Indicators Project and changes in the adequacy of hemodialysis between 1993 and 1996. Improvement of hemodialysis adequacy was measured by baseline and annual urea reduction ratios (URRs) in representative samples of ESRD Network patients. Random samples of in-center hemodialysis patients aged 18 years and older who had received hemodialysis during the fourth quarters of 1993, 1994, 1995, and 1996 were used to calculate Network-specific outcomes. A mean URR was calculated for each patient using the first pretreatment and posttreatment blood urea nitrogen for October, November, and December of each study year. Both national and Network-specific interventions were used to provide feedback reports and technical assistance to treatment centers to foster improvement in hemodialysis adequacy. All Networks distributed reports on the patterns of treatment center URR levels and physician and patient educational materials to each center in the Network. Each Network selected an annual 10% sample of treatment centers in 1994 and 1995 and conducted quality improvement activities to assist the selected centers to improve dialysis adequacy. We defined Network-specific interventions by a survey of the 18 Networks conducted during 1995 to determine the characteristics of Network-specific activities used to improve adequacy of hemodialysis. The outcome of interest was the change over time in Network-specific URR value. Sustained improvement in the URR occurred within all 18 Networks between 1993 and 1996. The mean national URR increased from 62.7% in 1993 to 66. 8% in 1996. The proportion of patients with URR >/= 65% increased from 43% in 1993 to 68% in 1996. Networks reported implementing a variety of intervention strategies that included educational activities, continuous quality improvement workshops, on-site assistance, and supervision of selected treatment facilities until care improved. Network-specific interventions independently associated with an increased rate of improvement in URR included prolonged supervision of the selected facilities. We concluded that the sustained improvement in hemodialysis care that occurred after the inception of the ESRD Core Indicators Project was associated with specific ESRD Network interventions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10585317     DOI: 10.1016/S0272-6386(99)70013-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

1.  Healthcare system interventions for inequality in quality: corrective action through evidence-based medicine.

Authors:  William F Owen; Lynda A Szczech; Diane L Frankenfield
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

2.  An empirical study of a hybrid imbalanced-class DT-RST classification procedure to elucidate therapeutic effects in uremia patients.

Authors:  You-Shyang Chen
Journal:  Med Biol Eng Comput       Date:  2016-04-06       Impact factor: 2.602

3.  Geographic concentration of poverty and arteriovenous fistula use among ESRD patients.

Authors:  William M McClellan; Haimanot Wasse; Ann C McClellan; James Holt; Jenna Krisher; Lance A Waller
Journal:  J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 10.121

4.  Development and validation of a survey to measure features of clinical networks.

Authors:  Bernadette Bea Brown; Mary Haines; Sandy Middleton; Christine Paul; Catherine D'Este; Emily Klineberg; Elizabeth Elliott
Journal:  BMC Health Serv Res       Date:  2016-09-30       Impact factor: 2.655

Review 5.  The effectiveness of clinical networks in improving quality of care and patient outcomes: a systematic review of quantitative and qualitative studies.

Authors:  Bernadette Bea Brown; Cyra Patel; Elizabeth McInnes; Nicholas Mays; Jane Young; Mary Haines
Journal:  BMC Health Serv Res       Date:  2016-08-08       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.